Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020 01; 72(1):78-88.

View in: PubMed

subject areas

Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antibodies, Antinuclear
Antibodies, Antinuclear
Anti-Citrullinated Protein Antibodies
Anti-Citrullinated Protein Antibodies
Autoantibodies
Autoantibodies
B-Lymphocytes
B-Lymphocytes
Case-Control Studies
Case-Control Studies
Complement Activation
Complement Activation
Complement C3
Complement C3
Complement C4
Complement C4
Complement C4b
Complement C4b
Disease Progression
Disease Progression
Erythrocytes
Erythrocytes
Female
Female
Flow Cytometry
Flow Cytometry
Humans
Humans
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Male
Male
Middle Aged
Middle Aged
Peptide Fragments
Peptide Fragments
Prospective Studies
Prospective Studies
Rheumatic Diseases
Rheumatic Diseases
Rheumatoid Factor
Rheumatoid Factor
Sjogren's Syndrome
Sjogren's Syndrome
Young Adult
Young Adult

authors with profiles

Cristina Arriens